Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXD1LI
|
||||
Drug Name |
4-{5-[4-(3-Chloro-phenyl)-3-oxo-piperazin-1-ylmethyl]-imidazol-1-ylmethyl}-2-(pyridin-3-yloxy)-benzonitrile
|
||||
Synonyms |
CHEMBL30270
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H23ClN6O2
|
||||
Canonical SMILES |
Clc1cccc(c1)N2CCN(Cc3cncn3Cc4ccc(C#N)c(Oc5cccnc5)c4)CC2=O
|
||||
InChI |
InChI=1S/C27H23ClN6O2/c28-22-3-1-4-23(12-22)34-10-9-32(18-27(34)35)17-24-14-31-19-33(24)16-20-6-7-21(13-29)26(11-20)36-25-5-2-8-30-15-25/h1-8,11-12,14-15,19H,9-10,16-18H2
|
||||
InChIKey |
YRERXVCECMZRBL-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.